您的位置: 首页 > 农业专利 > 详情页

Combination of PD-1 antagonist with an EGFR inhibitor
专利权人:
Novartis AG
发明人:
Jia, Yong,Kasibhatla, Shailaja,Bilic, Sanela,Cameron, John,Howard Jr., Danny
申请号:
AU2016298823
公开号:
AU2016298823A1
申请日:
2016.07.27
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides the use of such a combination for the manufacture of a medicament; the use of such a combination as a medicine; a kit of part comprising such a combination; and a method of treatment of such a combination.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充